Press release
Vascular Stents Market USD 11.15B in 2025 | 5.5% CAGR
Why Is the Vascular Stents Market Growing Rapidly?
What is driving the rising demand for vascular stents across the world? The answer lies in the growing burden of cardiovascular and peripheral vascular diseases, aging populations, and continuous innovation in interventional cardiology. The Vascular Stents Market has become a critical segment of the global medical devices industry, enabling minimally invasive treatment of narrowed or blocked blood vessels and significantly improving patient outcomes.
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, while conditions such as peripheral artery disease (PAD) and aortic aneurysms are increasing due to sedentary lifestyles, diabetes, obesity, and smoking. Vascular stents play a vital role in restoring blood flow, reducing complications, and shortening recovery times compared to open surgical procedures.
In 2025, the global vascular stents market reached a value of USD 11.15 billion. Supported by strong clinical adoption and technological advancements, the market is projected to grow at a CAGR of 5.50% from 2026 to 2035, reaching nearly USD 19.05 billion by 2035.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample.
Vascular Stents Market Overview
Vascular stents are small, expandable mesh tubes inserted into arteries or veins to keep them open after angioplasty or to support vessel walls. They are widely used in cardiology, vascular surgery, and interventional radiology.
Key Features of the Market
Strong integration with minimally invasive procedures
Continuous innovation in materials and drug coatings
High dependence on clinical evidence and long-term outcomes
Broad applications across coronary, peripheral, and endovascular therapies
The vascular stents market benefits from strong physician trust, standardized clinical guidelines, and rising procedural volumes globally.
Market Size and Growth Outlook (2026-2035)
The vascular stents industry demonstrates steady, sustainable growth due to its essential role in cardiovascular care.
Market value (2025): USD 11.15 Billion
Projected value (2035): USD 19.05 Billion
CAGR (2026-2035): 5.50%
Growth is fueled by increasing interventional procedures, expanding healthcare infrastructure, and improved access to advanced medical devices.
Key Growth Drivers of the Vascular Stents Market
1. Rising Prevalence of Cardiovascular Diseases
Coronary artery disease, peripheral artery disease, and cerebrovascular conditions are increasing globally. Vascular stents are central to treating these conditions effectively and safely.
2. Aging Global Population
Older adults are more susceptible to atherosclerosis and vascular blockages, driving higher demand for stent-based interventions.
3. Shift Toward Minimally Invasive Procedures
Compared to open surgery, stenting procedures offer:
Shorter hospital stays
Faster recovery times
Lower procedural risks
This shift significantly boosts adoption across hospitals and cardiac centers.
4. Technological Advancements in Stent Design
Innovations such as thinner struts, improved flexibility, and advanced drug coatings enhance safety, efficacy, and long-term vessel patency.
5. Expanding Access to Cardiac Care in Emerging Markets
Improving healthcare infrastructure and rising awareness in Asia Pacific and Latin America are accelerating procedural volumes.
Emerging Trends in the Vascular Stents Market
Growth of Drug-Eluting Stents (DES)
Drug-eluting stents release antiproliferative drugs that reduce restenosis rates, making them the preferred choice in coronary interventions.
Increasing Adoption of Bioabsorbable Stents
Bioabsorbable stents dissolve over time, reducing long-term complications and restoring natural vessel function, though adoption is still evolving.
Focus on Peripheral and EVAR Applications
Demand is expanding beyond coronary stents into peripheral vascular stents and EVAR stent grafts for complex vascular conditions.
Emphasis on Clinical Evidence and Real-World Data
Manufacturers increasingly invest in long-term clinical trials to support regulatory approvals and physician confidence, strengthening E-E-A-T signals.
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/vascular-stents-market.
Market Segmentation Analysis
Market Breakup by Type
Drug-Eluting Stents
Drug-eluting stents dominate the vascular stents market due to their ability to reduce restenosis and improve long-term outcomes, especially in coronary artery disease.
Bare-Metal Stents
Bare-metal stents remain relevant in specific patient populations where prolonged dual antiplatelet therapy is not suitable.
Bioabsorbable Stents
This segment represents an emerging opportunity, driven by innovation and demand for temporary scaffolding solutions.
Market Breakup by Product Type
Coronary Stents
Coronary stents account for the largest market share due to the high prevalence of coronary artery disease worldwide.
Peripheral Vascular Stents
Peripheral stents are increasingly used for treating PAD in the legs, carotid arteries, and renal arteries.
EVAR Stent Grafts
EVAR stent grafts are essential for endovascular aneurysm repair, offering a minimally invasive alternative to open surgery.
Others
Includes neurovascular and venous stents used in specialized procedures.
Market Breakup by Material
Metallic Stents
Metallic stents, primarily made of stainless steel, cobalt-chromium, or nitinol, dominate the market due to strength, flexibility, and durability.
Others
Includes polymer-based and hybrid materials, particularly in bioabsorbable designs.
Market Breakup by Mode of Delivery
Balloon-Expandable Stents
Balloon-expandable stents offer precise placement and are commonly used in coronary and renal arteries.
Self-Expanding Stents
Self-expanding stents provide superior flexibility and are widely used in peripheral and carotid arteries.
Market Breakup by End User
Hospitals and Cardiac Centres
Hospitals and specialized cardiac centers represent the largest end-user segment due to high procedural volumes and advanced infrastructure.
Ambulatory Surgical Centres
ASCs are gaining traction for select vascular procedures due to cost efficiency and shorter patient stays.
Others
Includes specialty clinics and research institutions.
Regional Analysis of the Vascular Stents Market
North America
North America leads the global vascular stents market, driven by high cardiovascular disease prevalence, advanced healthcare systems, and strong reimbursement frameworks. The United States accounts for the majority of regional revenue.
Europe
Europe holds a significant market share supported by aging demographics, strong clinical guidelines, and widespread adoption of advanced stent technologies.
Asia Pacific
Asia Pacific is the fastest-growing region, fueled by large patient populations, improving access to interventional cardiology, and rising healthcare investments in China, India, and Southeast Asia.
Latin America
Growth in Latin America is supported by expanding private healthcare systems and increasing awareness of minimally invasive cardiac treatments.
Middle East and Africa
This region shows gradual growth as cardiac care infrastructure improves, particularly in urban centers and GCC countries.
Competitive Landscape and Key Players
The vascular stents market is competitive and innovation-driven, with global leaders focusing on product differentiation, clinical validation, and geographic expansion.
Companies Covered
Abbott Laboratories
Boston Scientific Corporation
Biotronik, Inc.
MicroPort Scientific Corporation
B. Braun Melsungen AG
Terumo Corporation
Meril Life Sciences Pvt. Ltd.
Medtronic
BD
Biosensors International Group, Ltd.
Lepu Medical Technology
Koninklijke Philips N.V.
Teleflex Incorporated
Key Competitive Strategies
Development of next-generation drug-eluting and bioabsorbable stents
Expansion into emerging markets
Strategic collaborations with hospitals and research institutions
Strong focus on regulatory approvals and post-market surveillance
Challenges Facing the Vascular Stents Market
Despite strong growth prospects, the market faces several challenges:
High cost of advanced stent technologies
Risk of restenosis and stent thrombosis
Stringent regulatory requirements
Pricing pressure from healthcare payers
Limited access in low-income regions
Addressing affordability, long-term safety, and equitable access will be critical for sustained market expansion.
Future Outlook: What's Next for the Vascular Stents Market?
The future of the Vascular Stents Market is closely tied to innovation in materials science, drug delivery, and procedural techniques. As patient outcomes and safety remain top priorities, manufacturers are expected to focus on:
Next-generation bioabsorbable and hybrid stents
Improved drug coatings and release mechanisms
Personalized stent selection based on patient anatomy
Integration of imaging and AI-assisted placement tools
By 2035, vascular stents will continue to play a central role in global cardiovascular care, supporting better outcomes and minimally invasive treatment pathways.
Find More Reports
India Disposable Medical Gloves Market - https://bit.ly/3lu8TC1.
India Hospital Beds Market - https://bit.ly/3MlzkdT.
India Insulin Pumps Market - https://bit.ly/444jqe2.
India Medical Gases Market - https://bit.ly/48R1QvN.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vascular Stents Market USD 11.15B in 2025 | 5.5% CAGR here
News-ID: 4339018 • Views: …
More Releases from Expert Market Research
Dental Implants Market 2025 | 5.0% CAGR
Dental Implants Market: Global Growth, Trends, and Forecast (2026-2035)
Why Is the Dental Implants Market Expanding Worldwide?
What is driving the growing preference for dental implants over traditional dentures and bridges? The answer lies in rising oral health awareness, advancements in implant technology, and increasing demand for long-lasting, natural-looking tooth replacement solutions. The Dental Implants Market has become a cornerstone of modern restorative dentistry, offering patients improved functionality, aesthetics, and quality of…
Topical Pain Relief Market to Reach USD 18.15B by 2035
Topical Pain Relief Market: Global Growth, Trends, and Forecast (2026-2035)
Why Is the Topical Pain Relief Market Gaining Momentum Worldwide?
How can people manage pain effectively without relying heavily on oral medications or systemic therapies? This question has become increasingly important as populations age and chronic pain conditions rise globally. The answer, for millions of patients and healthcare providers, lies in the Topical Pain Relief Market.
Topical pain relief products-applied directly to the…
Remote Healthcare Market Growth at 18.3% CAGR to 2035
Remote Healthcare Market: Global Growth, Trends, and Forecast 2026-2035
Why Is the Remote Healthcare Market Expanding So Rapidly?
How can healthcare systems deliver high-quality care while overcoming barriers such as distance, workforce shortages, and rising costs? This question is at the heart of the Remote Healthcare Market, one of the fastest-growing segments of the global digital health ecosystem. Remote healthcare-often referred to as telehealth, telemedicine, or virtual care-leverages digital technologies to deliver…
Pigmentation Disorder Treatment Market Growth at 7.1% CAGR
Pigmentation Disorder Treatment Market: Global Growth, Trends, and Forecast 2026-2035
Why Is the Demand for Pigmentation Disorder Treatments Rising Globally?
Why are pigmentation disorders such as vitiligo, melasma, and post-inflammatory hyperpigmentation gaining increasing clinical and commercial attention worldwide? The answer lies in a combination of rising skin health awareness, lifestyle and environmental factors, and rapid advances in dermatological science. The Pigmentation Disorder Treatment Market has evolved significantly over the past decade, moving…
More Releases for Stent
Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What is the Airway Stent/Lung Stent Market and Why is It Significant?
The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,…
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
